- Conditions
- ER+ Breast Cancer, HER2-negative Breast Cancer
- Locations
-
- Institut de Cancérologie de l'Ouest Angers, France
- Centre Hospitalier Annecy Genevois_Site d'Annecy Annecy, France
- Institut du Cancer Avignon Sainte Catherine Avignon, France
- Centre Hospitalier Simone Veil de Blois Blois, France
Clinical trial condition
HER2-negative Breast Cancer
Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.
109 public trials
55 recruiting studies
HER2-negative Breast Cancer trial results
NCT06102824
- Conditions
- Advanced Breast Cancer, HER2-negative Breast Cancer
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
NCT05594095
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +8 more
- Locations
-
- Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
NCT05452213
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Cancer Female, +9 more
- Locations
-
- Department of Gynecology and Obstetrics, Erlangen University Hospital Erlangen, Bavaria, Germany
- Department of Gynecology and Obstetrics, University Medicine Mainz Mainz, Hesse, Germany
- Department for Gynecology and Obstetrics, Marienhospital Bottrop gGmbH Bottrop, North Rhine-Westphalia, Germany
- Klinikum St Marien Amberg Amberg, Germany
NCT04576143
- Conditions
- HER2-negative Breast Cancer, Neoadjuvant Chemotherapy
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT07827573
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
- Locations
-
Not specified
Not yet recruiting
Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases
NCT07466927
- Conditions
- HER2-negative Breast Cancer
- Locations
-
- Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Not yet recruiting
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
NCT06407401
- Conditions
- Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, +17 more
- Locations
-
Not specified
Active, not recruiting
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT04584255
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Yale University Cancer Center New Haven, Connecticut, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, not recruiting
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
NCT05508906
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- University of California San Francisco Health San Francisco, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Advent Health Hematology and Oncology Orlando, Florida, United States